What does Oncurious do?

Oncurious is a healthcare practice in Brussel. Public Limited, started on 3 April 2015, 1 establishment.

What is the address of Oncurious?

The registered office of Oncurious is located at Werkhuizenkaai 160, 1000 Brussel.

Is Oncurious still active?

Yes. According to the CBE (29 October 2026) Oncurious is active, legal situation “Normale toestand”, started on 3 April 2015.

Is Oncurious registered on Peppol?

Yes, Oncurious is registered on the Peppol network with ID 0208:0627952462.

What is the enterprise number of Oncurious?

The enterprise number of Oncurious is BE0627952462.

When was Oncurious founded?

Oncurious was founded on 3 April 2015.

Who are the directors of Oncurious?

According to the 2025 annual accounts, the directors of Oncurious are: MARS SARL, Vizelu SRL, Jonas Troesh.

Is Oncurious a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 April 2015; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did Oncurious make in 2025?

Oncurious recorded a loss after taxes of € 6,278 in financial year 2025.

What is the revenue of Oncurious?

As a small company, Oncurious is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -5,951.

Oncurious (Public Limited) - Brussel - BE0627952462

Dossier Oncurious, printed on 29 October 2026 from databakkes.be/en/0627952462/oncurious. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Busy address KBO

34 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

Oncurious from Brussel, company number BE0627952462, closed financial year 2025 with a result of € -6,278 after tax. For that financial year Oncurious recorded a gross margin of € -5,951 and equity of € 90,265. Compared with financial year 2024, the result moved from € -27,977 to € -6,278. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Healthy

€ 90,265

▼ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -6,278

▲ 78 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3

▼ € 82,773 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -7.5 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 26,768

▲ 24% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -46,606 Gross margin 2022: € -46,606 First fiscal year in the series	€ -6,397 Gross margin 2023: € -6,397 ▲ € 40,209 vs 2022 (€ -46,606) Favourable step	€ -20,722 Gross margin 2024: € -20,722 ▼ € 14,325 vs 2023 (€ -6,397) Unfavourable step	€ -5,951 Gross margin 2025: € -5,951 ▲ € 14,770 vs 2024 (€ -20,722) Favourable step	▲ € 14,770
Profit after taxes	€ -47,942 Profit after taxes 2022: € -47,942 First fiscal year in the series	€ -13,718 Profit after taxes 2023: € -13,718 ▲ € 34,225 vs 2022 (€ -47,942) Favourable step	€ -27,977 Profit after taxes 2024: € -27,977 ▼ € 14,259 vs 2023 (€ -13,718) Unfavourable step	€ -6,278 Profit after taxes 2025: € -6,278 ▲ € 21,699 vs 2024 (€ -27,977) Favourable step	▲ € 21,699
Equity	€ 138,237 Equity 2022: € 138,237 First fiscal year in the series	€ 124,520 Equity 2023: € 124,520 ▼ 10% vs 2022 (€ 138,237) Unfavourable step	€ 96,543 Equity 2024: € 96,543 ▼ 22% vs 2023 (€ 124,520) Unfavourable step	€ 90,265 Equity 2025: € 90,265 ▼ 7% vs 2024 (€ 96,543) Unfavourable step	▼ 7%
Total debts	€ 345,825 Total debts 2022: € 345,825 First fiscal year in the series	€ 213,850 Total debts 2023: € 213,850 ▼ 38% vs 2022 (€ 345,825) Favourable step	€ 146,726 Total debts 2024: € 146,726 ▼ 31% vs 2023 (€ 213,850) Favourable step	€ 70,197 Total debts 2025: € 70,197 ▼ 52% vs 2024 (€ 146,726) Favourable step	▼ 52%
Cash	€ 136,107 Cash 2022: € 136,107 First fiscal year in the series	€ 25,804 Cash 2023: € 25,804 ▼ 81% vs 2022 (€ 136,107) Unfavourable step	€ 82,776 Cash 2024: € 82,776 ▲ 221% vs 2023 (€ 25,804) Favourable step	€ 3 Cash 2025: € 3 ▼ € 82,773 vs 2024 (€ 82,776) Unfavourable step	▼ € 82,773
Retained profit	€ -7,435,137 Retained profit 2022: € -7,435,137 First fiscal year in the series	€ -7,448,854 Retained profit 2023: € -7,448,854 Unchanged (€ -7,435,137) Unfavourable step	€ -7,476,831 Retained profit 2024: € -7,476,831 Unchanged (€ -7,448,854) Unfavourable step	€ -7,483,109 Retained profit 2025: € -7,483,109 Unchanged (€ -7,476,831) Unfavourable step
Balance sheet total	€ 484,062 Balance sheet total 2022: € 484,062 First fiscal year in the series	€ 338,369 Balance sheet total 2023: € 338,369 ▼ 30% vs 2022 (€ 484,062) Unchanged	€ 243,269 Balance sheet total 2024: € 243,269 ▼ 28% vs 2023 (€ 338,369) Unchanged	€ 160,462 Balance sheet total 2025: € 160,462 ▼ 34% vs 2024 (€ 243,269) Unchanged	▼ 34%

Key figures of Oncurious, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Oncurious?

What happened at Oncurious in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2032 Jonas Troesh stepped down as director. NBB
2030 MARS SARL stepped down as director. NBB
Sep 30, 2026 New annual accounts for financial year 2025: loss of € 6,278. filed late Source: NBB ↗
2026 Vizelu SRL stepped down as director. NBB
2026 Jonas Troesh became a director. NBB
2024 MARS SARL became a director. NBB
2024 Vizelu SRL became a director. NBB
Jun 1, 2017 New establishment in Brussel. KBO

In short

From € 47,942 loss in 2022 to € 6,278 loss in 2025.

Original PDFs at the National Bank ↗

Management

Oxurion 100%

The stake of Oxurion comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Oncurious

The shares are held by Oxurion (100%).

Directors

According to the 2025 annual accounts

MARS SARL

Director · represented by Pascal Ghoson

Also active at: Oxurion

since 2024 · until 2030

Vizelu SRL

Director · represented by Samuel Darcheville

since 2024 · until 2026

Jonas Troesh

Director

since 2026 · until 2032

Shareholders

Oxurion

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Werkhuizenkaai 160

1000 Brussel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 34 companies are registered at this address.

All companies at this address →

ABM TRANSPORT

€ 675,460 gross margin · 2025

ASSOCIATION DES COMMERCANTS DE LA RUE BRABANT, LIEDTS ET GALLAIT

€ 30,081 gross margin · 2023

IODIS

€ 81,647 gross margin · 2025

INDEED BELGIUM OPERATIONS

€ 8.4 million gross margin · 2026

B-Progress NV

€ 961,729 gross margin · 2025

+29 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0627.952.462

VAT number

BE 0627.952.462

Registered office

Werkhuizenkaai 160, 1000 Brussel

Names & denominations

Oncurious

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

3 April 2015

Peppol

Active · Active since 17 Dec 2025

Contact

+3216751310

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

Oncurious

Warning lights

Financials

What happened to Oncurious?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions